Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana

Figures & data

Figure 1 Prescribing patterns of anti-glaucoma medications.

Figure 2 Distribution patterns for prostaglandin analogs.

Figure 3 Distribution patterns for beta adrenergic blockers.

Figure 4 Distribution patterns for monotherapy prescribed.

Table 1 Cost Analysis of Various Anti-Glaucoma Medicines

Type of Various Anti-Glaucoma Therapy (Generic/Proprietary)	Concentration	Millimeters	Cost/Bottle	Cost/mL	Dose/Day	Cost/Day	Cost/Month
		mL	GHC	GHC	Both Eyes (Drops)	GHC	GHC
Latanoprost-Proxinol	0.5%	2.5mls	40	16	2	1.18	35.5
Latanoprost-Texop	0.5%	2.5mls	65	26	2	1.93	57.7
Latanoprost- Xalatan	0.5%	2.5mls	130	52	2	3.6	115.6
Bimatoprost-Lumigan	0.3%	3mls	103	34.3	2	3.05	91.6
Timolol- UK Brand	0.5%	5mls	5	1	4	0.14	4.5
Timolol- Cusimolol	0.5%	5mls	20	4	4	0.59	17.8
Timolol-Epitimol	0.5%	5mls	12	2.4	4	0.36	10.7
Levobunolol- Betagan	0.5%	5mls	18.5	3.7	4	0.54	16.4
Timolol + Brinomidine (Combigan)	0.5% + 0.2%	5mL	89	17.8	4	2.6	79.1
Timolol + Dorzolamide (Episoft)	0.5%  +  2%	5mL	66	13.2	4	1.96	58.7
Travoprost -Travatan	0.004%	2.5mL	165	66	2	4.9	146.7
Brimonidine- Alphagan	2%	5mls	84	17	4	2.4	74.6
Brinzolamide- Azopt	0.2%	5mls	132	26.4	6	5.8	175.9